These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32047561)

  • 1. Genome-wide Analysis of the Alternative Splicing Profiles Revealed Novel Prognostic Index for Kidney Renal Cell Clear Cell Carcinoma.
    Gao L; He RQ; Huang ZG; Dang YW; Gu YY; Yan HB; Li SH; Chen G
    J Cancer; 2020; 11(6):1542-1554. PubMed ID: 32047561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
    Chen T; Zheng W; Chen J; Lin S; Zou Z; Li X; Tan Z
    J Cell Biochem; 2020 Oct; 121(10):4074-4084. PubMed ID: 31886566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. System analysis of
    Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
    Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landscape analysis of alternative splicing in kidney renal clear cell carcinoma and their clinical significance.
    Cheng S; Zhou Z; Liu J; Li J; Wang Y; Xiao J; Luo Y
    Aging (Albany NY); 2024 Jun; 16(11):10016-10032. PubMed ID: 38862257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognosis-related alternative splicing events in kidney renal clear cell carcinoma.
    Zuo Y; Zhang L; Tang W; Tang W
    J Cell Mol Med; 2019 Nov; 23(11):7762-7772. PubMed ID: 31489763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.
    Xiao L; Zou G; Cheng R; Wang P; Ma K; Cao H; Zhou W; Jin X; Xu Z; Huang Y; Lin X; Nie H; Jiang Q
    BMC Cancer; 2021 Jun; 21(1):703. PubMed ID: 34130646
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
    Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma.
    Meng T; Huang R; Zeng Z; Huang Z; Yin H; Jiao C; Yan P; Hu P; Zhu X; Li Z; Song D; Zhang J; Cheng L
    Front Bioeng Biotechnol; 2019; 7():270. PubMed ID: 31681747
    [No Abstract]   [Full Text] [Related]  

  • 10. The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas.
    Ball MW; Gorin MA; Drake CG; Hammers HJ; Allaf ME
    Eur Urol Focus; 2017 Dec; 3(6):584-589. PubMed ID: 28753846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
    Xing Q; Ji C; Zhu B; Cong R; Wang Y
    Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Identification of Survival-Associated Alternative Splicing Events in Kidney Renal Clear Cell Carcinoma.
    Wei Y; Zhang Z; Peng R; Sun Y; Zhang L; Liu H
    Comput Math Methods Med; 2021; 2021():5576933. PubMed ID: 33959190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma.
    Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J
    Front Genet; 2020; 11():568192. PubMed ID: 33133154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
    Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
    Front Oncol; 2020; 10():570819. PubMed ID: 33628726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of
    Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
    Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictive values of Notch signalling in renal carcinoma.
    Jędroszka D; Orzechowska M; Bednarek AK
    Arch Med Sci; 2017 Oct; 13(6):1249-1254. PubMed ID: 29181054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival-Associated Alternative Splicing Events in Pan-Renal Cell Carcinoma.
    Jia K; Wu Y; Huang J; Wu H
    Front Oncol; 2019; 9():1317. PubMed ID: 31850211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An
    Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
    Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
    Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
    Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing and Validating the Prognostic Value of a TNF-Related Signature in Kidney Renal Clear Cell Carcinoma.
    Zhang W; Li C; Wu F; Li N; Wang Y; Hu Y; Fang T; Yuan H; He H
    Front Mol Biosci; 2021; 8():689037. PubMed ID: 34124165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.